MedPath

euromuscular electrical stimulation to enhance the exercise benefits for muscle functions during spaceflight

Not Applicable
Recruiting
Conditions
M62.5
Muscle wasting and atrophy, not elsewhere classified
Registration Number
DRKS00032106
Lead Sponsor
niversität Trieste
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
16
Inclusion Criteria

Astronauts from ESA, NASA, the Japanese or Canadian space agencies flying to the ISS.

Exclusion Criteria

- Subjects with ferromagnetic metal implants, pacemakers or electronic materials cannot be included in the study due to the MRI scan
- Previous head surgery with metal implants
- Claustrophobia
- Previous knee surgery or ligament injuries
- Personal or family history of epilepsy, uncontrolled high blood pressure, bleeding tendency, use of aspirin or warfarin, impaired blood clotting, history of nerve, muscular or skeletal disorders of the leg
- Allergies to kinesiology tape, stickers, electrode gel or Aquasonic ultrasound gel
- Cardiac diseases
- Pregnant women
- MRI cannot be performed on persons with:
Implanted pacemakers
Intracranial aneurysm clips
Cochlear implants
Certain prosthetic devices
Implanted drug infusion pumps
Neurostimulators
Bone growth stimulators
Certain intrauterine contraceptive devices (e.g. with iron-based metal)
All other types of iron-based metal implants.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurements before and immediately after spaceflight of: <br>- Muscle neuromuscular functions (muscle strength, fatigue resistance, voluntary activation capacity, motor unit function), muscle volume and architecture (MRI) <br>- Muscle perfusion (SO2, blood flow, Hb content) measured with NIRS and O2C <br>- Maximum oxygen uptake (V'O2) and maximum CO2 release (V'CO2) <br>- Blood analyses: circulating myokines, microRNAs, inflammatory and angiogenesis biomarkers, parameters of neuromuscular interaction, muscle physiology, etc. <br>- Questionnaires (muscular symptoms, previous diseases etc.)
Secondary Outcome Measures
NameTimeMethod
Comparison of the degree of muscular degradation due to the stay in weightlessness between the intervention and control groups
© Copyright 2025. All Rights Reserved by MedPath